|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Pharm Exec's Emerging Pharma Leaders 2018almost 7 years ago
Choosing the Right Track: Pharma & Healthcare MBAsabout 7 years ago
Getting Where You Need to Goabout 7 years ago
Vienna’s Vision on Health Regulation in Europeabout 7 years ago
FDA Launches Major Push for New Antimicrobialsabout 7 years ago
Medical Affairs’ Search for MeaningNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
3
Novo Nordisk Stock Reacts to Recent Board Changes
4
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
5
